(Q40920804)

24 September 2017

1 reference

title

Drug treatment of depression in the 1990s. An overview of achievements and future possibilities (English)

1 reference

24 September 2017

H J Möller

1

1 reference

PubMed ID

9118813

24 September 2017

H P Volz

series ordinal

2

1 reference

24 September 2017

1 November 1996

1 reference

24 September 2017

1 reference

24 September 2017

52

1 reference

24 September 2017

625-638

1 reference

24 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199652050-00001

24 September 2017

0 references

cites work

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

1 reference

12 December 2020

Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug

1 reference

12 December 2020

A comparison of moclobemide, amitriptyline and placebo in depression: a Canadian multicentre study

1 reference

12 December 2020

On the reversibility of reversible MAO inhibitors.

1 reference

12 December 2020

Antidepressant drug selection: criteria and options.

1 reference

12 December 2020

Sertraline in the prevention of depression

1 reference

12 December 2020

Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative

1 reference

12 December 2020

Double-blind comparison of moclobemide and tranylcypromine in depression

1 reference

12 December 2020

The potential benefits of serotonin receptor-specific agents.

1 reference

12 December 2020

Monoamine oxidase inhibition by the MAO-A inhibitors brofaromine and clorgyline in healthy volunteers

1 reference

12 December 2020

A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression

1 reference

12 December 2020

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

The clinical utility of pharmacological agents that act at serotonin receptors

1 reference

12 December 2020

A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression

1 reference

12 December 2020

The inhibition of monoamine oxidase by brofaromine

1 reference

12 December 2020

Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjects

1 reference

12 December 2020

Nefazodone--a novel antidepressant--may increase REM sleep

1 reference

12 December 2020

Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study.

1 reference

12 December 2020

Fluoxetine in tricyclic refractory major depressive disorder

1 reference

12 December 2020

Safety of mirtazapine: a review

1 reference

12 December 2020

Tyramine potentiation during treatment with MAO inhibitors: brofaromine and moclobemide vs irreversible inhibitors

1 reference

12 December 2020

Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression

1 reference

12 December 2020

A Placebo-controlled Study of the Antidepressant Activity of Moclobemide,A New MAO-A Inhibitor

1 reference

12 December 2020

Safety and efficacy during long-term treatment with moclobemide

1 reference

12 December 2020

Serotonergic mechanisms and current and future psychiatric practice.

1 reference

12 December 2020

Citalopram 20 mg, citalopram 40 mg and placebo in the prevention of relapse of major depression

1 reference

12 December 2020

Clinical efficacy of paroxetine in resistant depression.

1 reference

12 December 2020

Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis

1 reference

12 December 2020

Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.

1 reference

12 December 2020

Moclobemide versus tranylcypromine in the treatment of depression

1 reference

12 December 2020

The effect of adrenergic drugs on serotonin metabolism in the nucleus raphe dorsalis of the rat, studied by in vivo voltammetry

1 reference

12 December 2020

Safety of moclobemide in clinical use.

1 reference

12 December 2020

Nefazodone: preclinical pharmacology of a new antidepressant

1 reference

12 December 2020

The role of venlafaxine in rational antidepressant therapy.

1 reference

12 December 2020

Long-term treatment of depression with nefazodone

1 reference

12 December 2020

Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors

1 reference

12 December 2020

Interactions of serotonin reuptake inhibitors with tricyclic antidepressants

1 reference

12 December 2020

Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

1 reference

12 December 2020

Comparative efficacy of antidepressants

1 reference

12 December 2020

Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder

1 reference

12 December 2020

Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

Efficacy of moclobemide in different patient groups: a meta-analysis of studies

1 reference

12 December 2020

Brofaromine--a review of its pharmacological properties and therapeutic use.

1 reference

12 December 2020

A quantitative analysis of clinical drug trials for the treatment of affective disorders

1 reference

12 December 2020

The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.

1 reference

12 December 2020

Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression

1 reference

12 December 2020

Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients

1 reference

12 December 2020

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.

1 reference

12 December 2020

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group

1 reference

12 December 2020

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

1 reference

12 December 2020

Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, org 3770 and its enantiomers

1 reference

12 December 2020

A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.

1 reference

12 December 2020

Moclobemide (Ro 11-1163) versus tranylcypromine in the treatment of endogenous depression

1 reference

12 December 2020

The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo

1 reference

12 December 2020

S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies.

1 reference

12 December 2020

The disposition of venlafaxine enantiomers in dogs, rats, and humans receiving venlafaxine

1 reference

12 December 2020

1 reference

12 December 2020

A double-blind comparison of nefazodone, imipramine, and placebo in major depression

1 reference

12 December 2020

Moclobemide and clomipramine in reactive depression. A placebo-controlled randomized clinical trial

1 reference

12 December 2020

The prophylactic efficacy of fluoxetine in unipolar depression

1 reference

12 December 2020

Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression

1 reference

12 December 2020

Nefazodone and imipramine in major depression: a placebo-controlled trial

1 reference

12 December 2020

A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression

1 reference

12 December 2020

A European study of views on the use of monoamine oxidase inhibitors

1 reference

12 December 2020

Metabolic disposition of 14C-venlafaxine in mouse, rat, dog, rhesus monkey and man

1 reference

12 December 2020

10.2165/00003495-199652050-00001

Identifiers

DOI

1 reference

PubMed ID

9118813

Dimensions Publication ID

24 September 2017

0 references

1 reference

PubMed ID

9118813